ArticleNature chemical biology2016
CRISPR-Cas9-based target validation for p53-reactivating model compounds.
Michael Wanzel et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
52 papers cite it
this paperpooled itcites it
ArticleNature chemical biology2016
Michael Wanzel et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.